Delivery Order SPE2DR25D3111-SPE2DR26FF3RL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,246.57 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges. The order is scheduled for completion by December 9, 2025, and utilizes firm fixed pricing with no set-aside designation, indicating the award resulted from open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,055.83 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 mL cartridges on October 14, 2025, with completion scheduled for October 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Imitrex (sumatriptan) is a migraine medication supplied to support military and federal healthcare system...
- The Defense Logistics Agency awarded a delivery order valued at $12,487.60 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml cartridges on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price contract represents a non-set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Imitrex is a migraine treatment medication, and this delivery order fulfills specific pharmaceutical supply needs for federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,895.22 to AmerisourceBergen Drug Corp for IMITREX 6 mg/0.5 mL cartridges on November 6, 2025, with an ultimate completion date of November 7, 2025. This non-competitive delivery order represents a firm fixed-price transaction issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $5,017.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges. This competitive award, issued without set-aside designation, is scheduled for completion by December 15, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges totaling $15,182.55 with completion expected by May 7, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $5,155.59 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Imitrex 6 mg/0.5 mL cartridges (0.5 mL units). This firm fixed-price contract represents a non-competitive delivery order with an ultimate completion date of August 11, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Imitrex 6 mg/0.5 ml cartridges (0.5 ml) under a firm fixed price contract valued at $1,819.68. The contract carries an ultimate completion date of June 3, 2025, and represents a non-competitive, non-set-aside award. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,913.45 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,682.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 mL cartridges (0.5 mL), with an ultimate completion date of August 1, 2025. This non-set-aside contract was competitively awarded on July 31, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3RLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,222.25 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 mL cartridges on December 17, 2025, with an ultimate completion date of December 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Imitrex (sumatriptan) is a prescription medication used for migraine treatment, reflecting the pharmaceutical supply needs of military and federal healthcare systems supported by the DLA. This delivery order represents a discrete transaction within AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of federal contracts covering a wide range of medications and medical supplies across multiple therapeutic categories. The company's demonstrated capability to fulfill federal procurement requirements through open competition has established it as a key supplier supporting Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/16/25 |